Evidence map›Paper›PMID 38915597›Full record

ArticlebioRxiv : the preprint server for biology2024

Converging cytokine and metabolite networks shape asymmetric T cell fate at the term human maternal-fetal interface.

Nicholas J Maurice, Jami R Erickson, Caitlin S DeJong, Florian Mair, Alexis K Taber, Marie Frutoso, Laura V Islas, Anna-Lena Bg Vigil, Richard L Lawler, M Juliana McElrath and 4 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Nicholas J MauriceMolecular and Cellular Biology Graduate Program, University of Washington, Seattle, WA.ORCID 0000-0002-2667-472X
Jami R EricksonVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.ORCID 0000-0002-4549-5217
Caitlin S DeJongVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.ORCID 0000-0002-5714-0077
Florian MairVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.ORCID 0000-0001-6732-5449
Alexis K TaberVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.ORCID 0000-0002-7012-3001
Marie FrutosoVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.ORCID 0000-0002-7848-1049
Laura V IslasVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.ORCID 0000-0003-1465-3718
Anna-Lena Bg VigilHuman Biology Division, Fred Hutchinson Cancer Center, Seattle, WA.ORCID 0000-0002-8521-9583
Richard L LawlerImmune Monitoring Core, Fred Hutchinson Cancer Center, Seattle, WA.
M Juliana McElrathVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.ORCID 0000-0003-2276-7117
Evan W NewellVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.ORCID 0000-0002-2889-243X
Lucas B SullivanHuman Biology Division, Fred Hutchinson Cancer Center, Seattle, WA.ORCID 0000-0002-6745-8222
Raj ShreeDivision of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Washington, Seattle, WA.ORCID 0000-0002-2747-2097
Stephen A McCartneyDivision of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Washington, Seattle, WA.ORCID 0000-0003-1102-6778

Funding

REPRODUCTIVE SCIENTIST TRAINING PROGRAMK12HD000849 · NICHD · WASHINGTON UNIVERSITY · PI Danny J Schust · 1988 to 2026
$33.2M
NRSA Training CoreTL1TR002318 · NCATS · UNIVERSITY OF WASHINGTON · PI Megan Moore · 2017 to 2026
$8.4M
The roles of EBV-specific T cells in response to checkpoint blockade immunotherapy of EBV-driven nasopharyngeal carcinomaR01CA264646 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI NEWELL, EVAN · 2021 to 2025
$3.0M
Single-Cell Analysis To Define Protective and Tolerizing Immune Cell Populations in the Human PlacentaR21AI144677 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PRLIC, MARTIN, SHREE, RAJ · 2020 to 2021
$570k
Profiling and leveraging bystander T cells within the tumor microenvironmentF99CA245735 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI MAURICE, NICHOLAS JOSEPH · 2019 to 2021
$94k
Investigating the Role of Dysregulated Immunity and Inflammation at the Maternal-Fetal Interface in PreeclampsiaF31HD098769 · NICHD · FRED HUTCHINSON CANCER RESEARCH CENTER · PI MAURICE, NICHOLAS JOSEPH · 2019 to 2019
$12k
NCATS NIH HHS TL1 TR002318NCI NIH HHS F99 CA245735NCI NIH HHS R01 CA264646NIAID NIH HHS R21 AI144677NICHD NIH HHS F31 HD098769NICHD NIH HHS K12 HD000849
6 · The paper itself

Abstract

Placentation presents immune conflict between mother and fetus, yet in normal pregnancy maternal immunity against infection is maintained without expense to fetal tolerance. This is believed to result from adaptations at the maternal-fetal interface (MFI) which affect T cell programming, but the identities (i.e., memory subsets and antigenic specificities) of T cells and the signals that mediate T cell fates and functions at the MFI remain poorly understood. We found intact recruitment programs as well as pro-inflammatory cytokine networks that can act on maternal T cells in an antigen-independent manner. These inflammatory signals elicit T cell expression of co-stimulatory receptors necessary for tissue retention, which can be engaged by local macrophages. Although pro-inflammatory molecules elicit T cell effector functions, we show that additional cytokine (TGF-β1) and metabolite (kynurenine) networks may converge to tune T cell function to those of sentinels. Together, we demonstrate an additional facet of fetal tolerance, wherein T cells are broadly recruited and restrained in an antigen-independent, cytokine/metabolite-dependent manner. These mechanisms provide insight into antigen-nonspecific T cell regulation, especially in tissue microenvironments where they are enriched.

Identifiers

PMID38915597
PMCPMC11195144

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.